[SRNE] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -146.66%
YoY- -54.89%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 15,025 16,251 15,594 17,400 11,461 18,385 13,076 9.73%
PBT -107,865 -142,790 -210,499 -91,702 -220,599 -38,946 -178,068 -28.47%
Tax 671 11,468 -1,814 -1,015 -1,050 1,463 -33,055 -
NP -95,212 -139,616 -223,692 -90,687 -219,549 -40,815 -144,417 -24.30%
Tax Rate - - - - - - - -
Total Cost 110,237 155,867 239,286 108,087 231,010 59,200 157,493 -21.21%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -633.69 -859.12 -1,434.47 -521.19 -1,915.62 -222.00 -1,104.44 -31.02%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.17 -0.26 0.00 -0.20 -0.55 -0.12 -0.47 -49.32%
EPS Diluted -0.17 -0.26 0.00 -0.20 -0.55 -0.12 -0.47 -49.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.